Skip to main content
    E

    Evogene (EVGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.34
    -0.05 (-13.17%)

    Market Cap: $6.70M

    Last updated: Nov 17, 2026 at 4:39 PM ET

    Evogene (EVGN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Evogene (EVGN) has a latest price of $0.34 on Nov 17, 2026, 73.0% below its 52-week high of $1.26. Its price fell 71.9% over the past 12 months. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $61.20 in Jan 2021 and its lowest $0.37 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart EVGN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EVGN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 43.4%, and over 6 months it fell 54.3%. The month-end price fell 92.2% over the 3 years through Oct 2026, a compound annual decline of 57.2%.

    PeriodChange
    1 month-7.6%
    3 months-43.4%
    6 months-54.3%
    12 months-71.9%
    12 months, with dividends-71.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-92.2%-57.2%
    5 years-98.6%-57.2%
    10 years-99.4%-39.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 209.2%, and its weakest was 2024, when it fell 77.7%.

    YearCloseChange
    2026 through Oct 2026$0.37-65.9%
    2025$1.10-41.2%
    2024$1.87-77.7%
    2023$8.40+20.0%
    2022$7.00-57.3%
    2021$16.40-65.1%
    2020$47.00+209.2%
    2019$15.20-23.2%
    2018$19.80-35.5%
    2017$30.70-39.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 15.6% below its 50-day average of $0.40 and 45.4% below its 200-day average of $0.62.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.34
    52-week high$1.26-73.0%
    52-week low$0.25+36.0%
    50-day average$0.40-15.6%
    200-day average$0.62-45.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.2%.

    MeasureValue
    1-year beta1.29
    Largest fall, 1 year-77.4%
    Largest fall, 3 years-97.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About EVGN

    What is EVGN's 1-year price change?

    Evogene's price fell 71.9% over the past 12 months. With dividends included, the 12-month total return was -71.9%.

    What is EVGN's 5-year price change?

    Evogene's month-end price fell 98.6% over the 5 years through Oct 2026, a compound annual decline of 57.2%. These figures leave out dividends.

    What is EVGN's 52-week high and low?

    Evogene's 52-week high is $1.26 and its 52-week low is $0.25. Its latest price of $0.34 on Nov 17, 2026 is 73.0% below the high.

    What is EVGN's beta?

    Evogene's 1-year beta against the S&P 500 is 1.29, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.4%.

    Is the EVGN chart free?

    Yes. Advanced Charting for EVGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.